Monday - November 16, 2026
University of Birmingham: New Spin-out IMS Solutions to Commercialise Groundbreaking 'steroid Fingerprint' Technology
September 22, 2026
BIRMINGHAM, England, Sept. 22 -- The University of Birmingham posted the following news:

* * *

New spin-out IMS Solutions to commercialise groundbreaking 'steroid fingerprint' technology

IMS is developing a world-first stratification test for Polyendocrine Metabolic Ovarian Syndrome and a more accurate diagnostic for Adrenocortical Carcinoma

22 September 2026

The University of Birmingham and Imperial College London have a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products